Loading...

Intravenous Thrombolysis in Expanded Time Window (3-4.5 hours) in General Practice with Concurrent Availability of Endovascular Treatment

INTRODUCTION: A randomized double-blind trial (ECASS III) demonstrated that intravenous (IV) recombinant tissue plasminogen activator (rt-PA) administered between 3 and 4.5 hrs after the onset of symptoms significantly improved clinical outcomes in patients with acute ischemic stroke. In May 2009, t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Tekle, Wondwossen G, Chaudhry, Saqib A, Fatima, Zara, Ahmed, Maryam, Khalil, Shujaat, Hassan, Ameer E, Rodriguez, Gustavo J, Suri, Fareed K, Qureshi, Adnan I
Format: Artigo
Sprog:Inglês
Udgivet: Zeenat Qureshi Stroke Research Center 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3379904/
https://ncbi.nlm.nih.gov/pubmed/22737262
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!